ArticleJournal of controlled release : official journal of the Controlled Release Society2022

Development of an extended half-life GM-CSF fusion protein for Parkinson's disease.

Pravin Yeapuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.